Next Article in Journal
Primary Human Blood Dendritic Cells for Cancer Immunotherapy—Tailoring the Immune Response by Dendritic Cell Maturation
Previous Article in Journal
Aptamers and Their Significant Role in Cancer Therapy and Diagnosis
Open AccessReview

Circulating MicroRNAs as Biomarkers and Mediators of Cell–Cell Communication in Cancer

AstraZeneca, R&D Oncology iMed, Room 33F83/7 Mereside, Alderley Park, Macclesfield SK10 4TG, UK
Academic Editor: Kenneth Cornetta
Biomedicines 2015, 3(4), 270-281;
Received: 30 September 2015 / Revised: 3 November 2015 / Accepted: 5 November 2015 / Published: 9 November 2015
The realization of personalized medicine for cancer will rely not only on the development of new therapies, but on biomarkers that direct these therapies to the right patient. MicroRNA expression profiles in the primary tumor have been shown to differ between cancer patients and healthy individuals, suggesting they might make useful biomarkers. However, examination of microRNA expression in the primary tumor requires an invasive biopsy procedure. More recently, microRNAs have been shown to be released from the primary tumor into the circulation where they can be utilized as non-invasive biomarkers to diagnose patients, predict prognosis, or indicate therapeutic response. This review provides an overview of the current use of circulating microRNAs as biomarkers as well as recent findings on their role in regulating cell signaling interactions in the tumor microenvironment. View Full-Text
Keywords: micron; circulating biomarker; cancer micron; circulating biomarker; cancer
Show Figures

Graphical abstract

MDPI and ACS Style

Taylor, M.A. Circulating MicroRNAs as Biomarkers and Mediators of Cell–Cell Communication in Cancer. Biomedicines 2015, 3, 270-281.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Search more from Scilit
Back to TopTop